Basic Information
| LncRNA/CircRNA Name | AK001796 |
| Synonyms | MIR4435-2HG, AGD2, AK001796, LINC00978, MIR4435-1HG, MIR4435-2HG |
| Region | GRCh38_2:111036776-111523376 |
| Ensemble | ENSG00000172965 |
| Refseq | NR_015395 |
| Regulatory Mechanism | Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Information of Cancer
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR |
| Sample | HCC tissue, cell lines ( SMMC-7721, Huh-7, MHCC-97H (97H), and MHCC-97L (97L) ) |
| Expression Pattern | up-regulated |
| Function Description | We showed that the lncRNA AK001796 expression was significantly up-regulated in HCC tissues and cell lines, compared to their controls, respectively. |
| Pubmed ID | 30915744 |
| Year | 2019 |
| Title | The long non-coding RNA AK001796 contributes to poor prognosis and tumor progression in hepatocellular carcinoma. |
External Links
| Links for AK001796 | GenBank HGNC Noncode |
| Links for hepatocellular carcinoma | Omim Cosmic |